PAX8 and ovarian cancer: Next, we wanted to define the transcriptional impact elicited by PAX8–MECOM complex and we performed RNA sequencing (RNA-seq) upon silencing of either PAX8 or MECOM in a panel of five ovarian cancer cell lines, which display the highest sensitivity to both PAX8 and MECOM knockdown (see below).